Related Experiment Video
Updated: Feb 9, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Travel-associated hepatitis A in Europe, 2009 to 2015
Julien Beauté1, Therese Westrell1, Daniela Schmid2
1European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
International travel remains a significant risk for hepatitis A virus (HAV) infection in Europe. While the risk has slightly decreased, children under 15 are disproportionately affected and require prioritized vaccination.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- International travel to regions with high hepatitis A virus (HAV) endemicity poses a risk for travelers from low-endemicity countries.
- Understanding travel-related HAV infection is crucial for public health interventions in Europe.
Purpose of the Study:
- To quantify the risk of hepatitis A infection among European travelers.
- To analyze trends in travel-associated HAV cases within the European Union/European Economic Area (EU/EEA).
Main Methods:
- Utilized hepatitis A surveillance data from 13 EU/EEA countries (2009-2015).
- Incorporated travel denominator data from the Statistical Office of the European Union.
- Defined travel-associated cases as those reported as imported.
Main Results:
- Over 18,800 confirmed HAV cases were reported, with 27.8% linked to travel.
- Children under 15 represented 39.8% of travel-associated cases.
- The overall risk decreased by 3.7% annually, with Africa posing the highest risk.
Conclusions:
- Travel continues to be a primary risk factor for HAV infection in the EU/EEA.
- A notable proportion of travel-related HAV cases occur in children, highlighting the need for targeted vaccination strategies.
- Public health efforts should focus on vaccination for young travelers to mitigate HAV risk.
Related Concept Videos
Travelling Waves
Water waves, sound waves, and seismic waves are some examples of mechanical waves. For water waves, the wave propagation medium is...
Traveling Waves: Lossless Lines
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Hepatic Drug Excretion: Influencing Factors

